What is Sangui Biotech International Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sangui Biotech International's Average Total Inventories for the quarter that ended in Mar. 2023 was $0.00 Mil. Sangui Biotech International's Revenue for the
three
months ended in Mar. 2023 was $0.02 Mil.
Sangui Biotech International's Inventory-to-Revenue for the quarter that ended in Mar. 2023 was 0.00.
Sangui Biotech International's Inventory-to-Revenue for the quarter that ended in Mar. 2023
stayed the same
from Dec. 2022 (0.00) to Dec. 2022 (0.00)
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sangui Biotech International Inventory-to-Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Sangui Biotech International Inventory-to-Revenue Chart
Competitive Comparison of Sangui Biotech International's Inventory-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Sangui Biotech International's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sangui Biotech International's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sangui Biotech International's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Sangui Biotech International's Inventory-to-Revenue falls into.
Sangui Biotech International Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sangui Biotech International's Inventory-to-Revenue for the fiscal year that ended in Jun. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sangui Biotech International (OTCPK:SGBI) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Sangui Biotech International's Days Inventory for the
three
months ended in Mar. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sangui Biotech International Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Sangui Biotech International's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Sangui Biotech International (Sangui Biotech International) Business Description
Sangui Biotech International Inc develops pharmaceutical, medical and cosmetic products, through its subsidiary. The company develops oxygen carriers for providing oxygen transport in humans due to acute or chronic lack of oxygen and in the case of chronic wounds. It has also developed external applications of oxygen transporters in the form of sprays for healing chronic wounds and gels and emulsions for the regeneration of the skin. The products offered are artificial oxygen carriers; Chitoskin wound pads; and haemoglobin-based wound spray technology sold under the brand name Granulox. It derives revenue from licensing fees on sales of its wound spray product.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SGBI has been successfully added to your 